NCT02228395View on ClinicalTrials.gov

Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-04958242 In Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 22, 2014

Primary Completion Date

November 13, 2014

Study Completion Date

November 13, 2014

Conditions
Healthy
Interventions
DRUG

PF-04958242

Administered as specified in treatment arm

DRUG

Placebo

Administered as specified in treatment arm

Trial Locations (1)

06511

New Haven Clinical Research Unit, New Haven

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY